1 a), we found that a single MTBVAC intravenous administration (5 × 10 6 CFUs), inoculated over sensitised mice, drove to a highly significant reduction of eosinophils compared to untreated group, both in lungs and BAL ( Fig. 1 b).
← all excerpts
Correlation between systemic allergen desensitisation and long-term asthma protection in mice following intravenous administration of the live tuberculosis vaccine MTBVAC.
1
—
—